Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and relative CVD risk in 76,600 patients with PC undergoing ET ...

Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are associated ...

A new tool may help patients better understand their long-term cardiovascular risk, researchers said. Based on the standard PREVENT risk calculator, researchers developed population-based age- and sex ...

Heart disease is the leading cause of death in the United States. Since researchers first established the link between diet, ...

4 Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Providencia, Chile 5 Universidad de Santiago de Chile (USACH), Escuela de Ciencias de la Actividad Física, el Deporte y la Salud, ...

CHD is a leading cause of death in industrialized nations. Hyperlipidemia with elevated serum total cholesterol, LDL-C and triglycerides is a known major cardiovascular risk factor. HDL-C is ...

India carries a heavy cardiometabolic burden of nearly 30%, intensified by early-onset diabetes, hypertension, dyslipidaemia, ...